# US 2013/0158450 A1 · Treatment of headache disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158450 A1
- Document ID: US20130158450A1
- Status: Published application
- Kind: A1
- Application number: 13/714,643
- Filed: 2012-12-14
- Published: 2013-06-20
- Earliest claimed: 2011-12-16
- Assignees: Chordate Medical AB
- Inventors: Jan-Erik JUTO; William HOLM; Fredrik JUTO
- Web page: https://patentgrep.com/patent/US20130158450A1

## CPC

- A61H 9/0078: {with intermittent or alternately inflated bladders or cuffs (mattresses for preventing bed-sores with alternated pressurized chambers A61G7/05776)}
- A61B 5/4824: {Touch or pain perception evaluation (A61B5/4821 takes precedence)}
- A61H 1/00: Apparatus for passive exercising (A61H5/00 takes precedence); Vibrating apparatus; Chiropractic devices, e.g. body impacting devices, external devices for briefly extending or aligning unbroken bones
- A61H 21/00: Massage devices for cavities of the body {, e.g. nose, ears and anus (for the genitals A61H19/00); Vibration or percussion related aspects A61H23/00}
- A61H 23/02: with electric or magnetic drive
- A61H 23/04: with hydraulic or pneumatic drive {(hydraulic or Pneumatic massages, A61H9/00; underwater massages, A61H33/00)}
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 20/70: relating to mental therapies, e.g. psychological therapy or autogenous training
- A61H 2201/0103: inflatable
- A61H 2201/5071: Pressure sensors
- A61H 2205/023: Nose
- A61H 2230/045: used as a control parameter for the apparatus
- A61H 2230/065: used as a control parameter for the apparatus
- A61H 2230/105: used as a control parameter for the apparatus
- A61H 2230/505: used as a control parameter for the apparatus
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A method for treatment of a headache disorder in a human subject is provided. The method comprises a) selecting a treatment area in the nasal cavity of the human subject; b) providing a stimulation member arranged for vibration stimulation of the selected treatment area; c) introducing the stimulation member into a nasal cavity of the human subject; d) expanding the stimulation member to exert a pressure on tissue of the selected treatment area; and e) bringing the stimulation member to vibrate in the nasal cavity to impart vibrations to the selected treatment area.

## Claims

### Claim 1

A method for treatment of a headache disorder in a human subject, comprising
a) selecting a treatment area in the nasal cavity of the human subject;
b) providing a stimulation member arranged for vibration stimulation of the selected treatment area;
c) introducing the stimulation member into a nasal cavity of the human subject;
d) expanding the stimulation member to exert a pressure on tissue of the selected treatment area; and
e) bringing the stimulation member to vibrate in the nasal cavity to impart vibrations to the selected treatment area.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the vibrations are imparted:
to a posterior part of the nasal cavity;
to an anterior part of the nasal cavity;
sequentially to a posterior and an anterior part of the nasal cavity; or
simultaneously to a posterior and an anterior part of the nasal cavity.

### Claim 3 (depends on 1)

The method according to claim 1, further comprising the step of imparting vibrations at at least one frequency selected from the range of approximately 40 to 100 Hz.

### Claim 4 (depends on 1)

The method according to claim 1, further comprising the step of exerting a pressure of between approximately 20 and 120 mbar on the tissue of the nasal cavity.

### Claim 5 (depends on 4)

The method according to claim 4, further comprising the step of initially exerting a first pressure on the tissue and subsequently exerting a second pressure on the tissue.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the pressures are selected from a range of between 20 and 80 mbar or from a range of between 81 and 120 mbar, wherein the first and second pressures are not selected from the same range.

### Claim 7 (depends on 1)

The method according to claim 1, further comprising the steps of obtaining an input signal reflecting a measure of a level of pain experienced by the human subject; and
analyzing the input signal and performing one or more acts to decrease the input signal reflecting a measure of pain, wherein the acts are selected from:
adjusting a frequency of the vibrations imparted to the nasal cavity;
adjusting an amplitude of the vibrations imparted to the nasal cavity;
adjusting a pressure exerted on the tissue of the nasal cavity; or
terminating vibration stimulation in a first nasal cavity and optionally continuing vibration stimulation in a second nasal cavity.

### Claim 8 (depends on 7)

The method according to claim 7, further comprising the steps of:
calculating and analyzing a derivative of the input signal reflecting a measure of pain; and
performing one or more of said acts.

### Claim 9 (depends on 7)

The method according to claim 7, wherein one or more of the acts are performed when either the input signal reflecting a measure of pain pass a first threshold, or when a derivative of the input signal passes a second threshold.

### Claim 10 (depends on 7)

The method according to claim 7, further comprising the step of terminating the treatment in the nasal cavity when either the input signal reflecting a measure of pain falls below a third threshold, when a maximum treatment time has elapsed, or when the derivative of the input signal is zero or within a derivative tolerance.

### Claim 11 (depends on 7)

The method according to claim 7, wherein said adjusting further comprises an adjustment selected from:
a random adjustment;
an amount calculated as a function of an elapsed treatment time, an initial value of the input signal reflecting a measure of pain, and a current value of the input signal reflecting a measure of pain; and
an amount calculated as a function of a derivative of the input signal reflecting a measure of pain and a time development of the pressure, frequency, and amplitude during the treatment.

### Claim 12 (depends on 7)

The method according to claim 7, wherein the input signal reflecting a measure of pain is obtained by fMRI.

### Claim 13 (depends on 7)

The method according to claim 7, wherein the input signal reflecting a measure of pain is an index on a VAS scale.

### Claim 14 (depends on 7)

The method according to claim 7, wherein the input signal reflecting a measure of pain is provided by the human subject.

### Claim 15 (depends on 1)

The method according to claim 1, further comprising the step of adjusting at least one of a pressure, a frequency and an amplitude of the vibrations, and repeating steps a) d) and e).

### Claim 16 (depends on 1)

The method according to claim 1, further comprising the steps of:
bringing the stimulation member to an essentially non-expanded state;
removing the stimulation member from the nasal cavity; and
repeating steps a) to e) in a second nasal cavity of the human subject.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the treatment target is selected from hypothalamus and sphenopalatine ganglion.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the stimulation member comprises at least one retaining portion and at least one stimulating portion.

### Claim 19 (depends on 1)

The method according to claim 1, wherein said providing comprises displaying information in a user interface on a type of stimulation member to use for the selected treatment area.

### Claim 20 (depends on 1)

The method according to claim 1, wherein the human subject suffers from a headache disorder selected from cluster headache, migraine, tension-type headache and medication-overuse headache.
